MaxCyte, Inc. (MXCT) Financials

MXCT Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 266.7 million 33.4 million
2023-06-30 271.2 million 30.2 million
2023-03-31 281.5 million 33.7 million
2022-12-31 286.7 million 32.7 million

MXCT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -9.0 million 3.6 million
2023-06-30 -10.6 million 3.5 million
2023-03-31 -5.9 million 3.3 million
2022-12-31 -8.3 million 3.1 million

MXCT Net Income

No data available :(

MXCT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 190.2 million - 16.1 million
2023-06-30 216.1 million - 16.2 million
2023-03-31 224.7 million - 16.3 million
2022-12-31 227.3 million - 16.1 million

MXCT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 103.4 million
2023-06-30 103.1 million
2023-03-31 102.8 million
2022-12-31 102.1 million

MXCT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 720200 6.3 million 6.8 million 7.0 million
2023-06-30 507000 5.7 million 7.7 million 6.4 million
2023-03-31 1.6 million 6.0 million 7.5 million 6.3 million
2022-12-31 2.2 million 5.7 million 5.6 million 5.4 million

MXCT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 8.0 million 793400
2023-06-30 9.0 million 1.4 million
2023-03-31 8.6 million 999800
2022-12-31 12.4 million 1.5 million

MXCT

Price: $3.83

52 week price:
2.45
5.55

Earnings Per Share: -0.37 USD

P/E Ratio: -13.22

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 508900

Market Capitalization: 429.8 million

Links: